COVID Next: Charting an Evolving Industry
Industry experts predict clinical diagnostics will continue evolving in the wake of COVID with automation, AI, and decentralized testing.
Read MorePosted by Chris Wolski | Mar 24, 2025 | Covid 19 |
Industry experts predict clinical diagnostics will continue evolving in the wake of COVID with automation, AI, and decentralized testing.
Read MorePosted by Chris Wolski | Mar 24, 2025 | Covid 19 |
The COVID-19 pandemic has reshaped healthcare, diagnostics, and public health preparedness, leaving lasting impacts on the industry.
Read MorePosted by Chris Wolski | Mar 20, 2025 | Lung Cancer |
Lung cancer screening has increased overall, but significant disparities remain, particularly among rural and underserved populations.
Read MorePosted by Chris Wolski | Mar 18, 2025 | Covid 19 |
The COVID-19 pandemic exposed weaknesses in global health preparedness, but now have significantly enhanced readiness for future pandemics.
Read MorePosted by Chris Wolski | Mar 18, 2025 | Amplification Technologies |
Diasorin has launched the Simplexa C. auris Direct kit to aid in identifying Candida auris and enhance infection control.
Read More